The most studied inflammasome, NLRP3, is the major culprit of chronic inflammation and microbial dysbiosis causing intestinal epithelial cells dysfunction and CRC oncogenesis; hence, there have been suggestions to use it as a potential therapeutic target for CRC [158]. Here, NLRP3 is linked to colorectal carcinoma.